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Hepatoblastoma (HB) is a rare malignant tumour of the liver and usually occurs in the ﬁrst three years of life. Most of these
tumours arise in the embryo; hence it seems to be unusual that hepatoblastoma occurs in adults and is an exceptional cause of
primary malignant liver tumour in adult patients. The diagnosis is often overlooked, and patients might be diagnosed at late stages
of the disease at risk of increased mortality. In this paper we report a case of a 30-year-old man with mixed hepatoblastoma and
abdominal pain, hepatomegaly and fever. The patient under went noninvasive diagnostic methods: duplex scanning, Computed
Tomography (CT), and Magnetic Resonance imaging (MRI). In our experience, despite the important role of histological sample
provided by biopsy in deﬁning the diagnosis, very important was the role of MRI, more than ultrasonography and enhanced CT.
The MRI detects tumor features as size, margins, and ratio with neighboring organs in order to get the best surgical approach.
1.Introduction
Epithelial carcinomas of liver are among the most frequent
malignant tumours that occur in adults [1]. Far more
than 90% represent either hepatocellular carcinoma (HCC)
or intrahepatic cholangiocarcinoma. Rare malignancies in
adults with epithelial diﬀerentiation include combined hep-
atocellular or cholangiocarcinoma, carcinosarcoma, oval or
stem-cell neoplasm, and hepatoblastoma [2].
Hepatoblastoma (HB) is a rare malignant tumour of
the liver and usually occurs in the ﬁrst three years of life
[3]. Most of these tumours arise in the embryo; hence it
seems to be unusual that hepatoblastomas occur in adults
and are an exceptional cause of primary malignant liver
tumour in adult patients [4]. Various synonymous have
been used to describe this kind of tumour such as hep-
atic embryonic mixed tumour, rhabdomyosarcohepatoma,
carcino-osteochondromyxosarcoma, and malignant mixed
hepatoblastoma [5].
However, the existence of HB in adult patients has been
refuted by some authors, with nonspeciﬁc initial symptoms
and diﬃculty in discerning abnormalities in laboratory data
of the patients [6, 7]. Consequently, the diagnosis is often
overlooked, and patients might be attended at a late stage of
the disease, at risk of increased mortality.
In this paper we report a case of mixed hepatoblastoma,




A 30-year-old man had been suﬀering from right hypochon-
driacpainandfever.Hehadnohistoryofthediseaseandhad
not received blood transfusion. Furthermore, there was not
family history of liver disease. Physical examination revealed
thattheliverwaspalpable5cmbelowtherightcostalmargin.
Laboratory data showed the following values: aspar-
tate aminotransferase (AST) 23IU/L; alanine aminotrans-
ferase (ALT) 18IU/L; total cholesterol 154mg/dL; negative
hepatitis B surface antigen, antihepatitis B antibody, and2 Case Reports in Medicine
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Figure 1: The Duplex scanning showed hepatomegaly (18cm of
longitudinal diameter) with presence of heterogeneous mass in the
right lobe.
antihepatitis C antibody; alpha-fetoprotein (AFP) 45ng/mL
and total bilirubina 1,71mg/dL, PCR 54, 50mg/L (0–5), VES
55mm/h (2–25). There was no evidence of liver cirrhosis.
Blood cultures and screening for tuberculosis were negative.
The patient under went noninvasive diagnostic methods:
duplexscanning,Computedtomography(CT)andMagnetic
Resonance imaging (MRI).
The Duplex scanning showed hepatomegaly (18cm of
longitudinal diameter) with presence of heterogeneous mass
in the right lobe. The mass was hyperechoic with some cal-
ciﬁcations and few anechoic foci, secondary to haemorrhage
and necrotic processes (Figure 1).
The color Doppler ultrasonography (US-CD) demon-
strated normal patency of sovrahepatic vessels.
Subsequently the patient was submitted to Computed
Tomography (CT) of abdomen (scanner:Highspeed Advan-
tage; GE Medical System Milwaukee, WI, USA).
Images were acquired without and with an intravenously
contrast media (a single bolus of 120cc with a ﬂow rate of
2.5mL/s of nonionic contrast medium via an antecubital
venous access), and scans were obtained with threephases
from the injection of contrast media.
The CT conﬁrmed a mass that occupied almost the
whole right lobe of the liver with lower attenuation than
surrounding liver on nonenhanced scan. After the injection
of the contrast media, it was assessed that the lesion
was predominantly of lower attenuation with some calci-
ﬁcations and small slit like or round and lower density
areas, corresponding to haemorrhage or necrosis. Contrast
enhancement was low and heterogeneous (Figure 2).
Magnetic Resonance imaging (MRI) with contrast media
demonstrated a 23 × 14 × 13cm mass in the right lobe.
This mass presented a well-deﬁned capsule. T1-weighted
images showed heterogeneous global intensity with areas
with intensity signal similar to haemoglobin metabolites,
areas with signal intensity similar to calciﬁcations and area
with signal intensity similar to fat. On T2-weighted images
the lesion was hyperintense but heterogeneous because
of hypointense areas corresponding to calciﬁcations and
bands corresponding to area of lobulation and ﬁbrosis.
Furthermore right kidney was displaced posteriorly by the
mass with its vascular pedicle (Figure 3).
Compressive eﬀects of the mass on sovrahepatic veins
were observed without occlusion, while gallbladder was
displaced but not inﬁltrated.
Related to MRI features was supposed a hepatoblastic
nature of the lesion.
Subsequent diagnostic imaging phase, a bioptic sample
was obtained with a CT-guided biopsy with 18G tru-cut
needle. Histopathologic examination revealed the presence
of mesenchymal and epithelial cells in bioptic specimen
and conﬁrmed the diagnosis of a mixed hepatoblastoma
(Figure 4).
After results of biopsy, surgical intervention was per-
formed in exploratory to resect the tumour. A right triseg-
mentectomy was performed with tumour grossly resected
with microscopic residual disease. The surgical diagnosis
conﬁrmed the diagnosis of a mixed hepatoblastoma.
No postprocedural complications were observed. He
is receiving the VI cycles of systemic chemotherapy whit
adriamycin and cisplatin which results in good health.
3. Discussion
HB is the most common primary malignant liver neoplasm
in children [8, 9]. Approximately 90% of the cases occur in
patients under 5 years of age, and two thirds of the cases
occur in the ﬁrst 2 years of life [10, 11]. HB in adolescent
andyoungadultsisextremelyrareneverthelesstheprognosis
is much worse than in childhood, because these kind of
tumoursareusuallydiagnosedlate[4,12].Somestudieshave
shown a male to female ratio for hepatoblastoma patients of
3-2:1 [13].
The etiology of HB has been elusive. Present investiga-
tions of the cytogenetic and molecular genetic abnormalities
in HB revealed involvement of chromosomal loci on 1q,
2 (or 2q), 4q, 8 (or 8q), and 20. Loss of heterozygosity
imprinting at locus 11p 15.5 also suggests a common genetic
basis for HB [14]. The detection of nuclear β-catenin
accumulation implies an oncogene alteration of the wnt/β-
catenin pathway. Furthermore, nuclear p53 accumulation
indicates that p53 mutation is also involved in the molecular
pathogenesisofthemalignancy[15].Basedonembryological
theory, it is believed that HB arises from a hepatic blastema.
However, this hypothesis seems to be inapplicable to adult
HB. Only four patients [6, 16, 17] in the literature were
more than 70 years old. The persistence of primitive hepatic
blastemaforsuchalongperiodseemsunlikely.Furthermore,
the presence of cirrhosis in liver with HB is not seen in
children.
However, cirrhosis of the liver has been seen in associa-
tion with adult HB in 30% of cases [6, 18]. In 20%–30% of
the cases, there are calciﬁcations in the mixed HB.
Thiswouldimplythatthesetumoursmayhaveadiﬀerent
pathogenetic pathway in adults compared to children.
Ishank and Glunz classiﬁed hepatoblastomas into two
groups: epithelial type and mixed epithelial and mesenchy-
mal type [19].Case Reports in Medicine 3
(a) (b)
(c) (d)
Figure 2: Computed Tomography (CT): axial arterial phase (a); coronal venous phase (c); MIP axial and coronal (b–d). The CT conﬁrmed
a mass with heterogeneous density that occupied almost the whole right lobe of the liver (a–c). MIP images showed compressive eﬀects of





showed heterogeneous contrast enhanced with enhancement of ﬁbrosis bands in tardive-phase (c–e). This heterogeneous mass occupied
almost the whole right lobe of the liver presenting a well-deﬁned capsule (f).4 Case Reports in Medicine
Figure 4: Microscopic examination of mass was composed by a
combination of mesenchymal and epithelial elements. The surgical
diagnosis conﬁrmed the mixed hepatoblastoma.
The epithelial type consists of fetal and embryonic
cells presenting alone or in combination; in the epithelio-
mesenchymalmixedtype,mesenchymalelementsarepresent
along with the epithelial component [20]. For a long time
it has been thought that hepatoblastoma develops during
intrauterine life, but the same histological pattern has been
seen in hepatic tumours in adults, and new data about its
histogenesis are emerging. An interesting theory looks at
the common hepatocytes as the starting point, after having
lost the diﬀerentiation and acquired new possibilities of
transformation [21].
In adults, the morbidity of HB is extremely rare, and the
initialsymptomsarenonspeciﬁcsothatthediagnosisisoften
overlooked. The usual presentation is failure to thrive,l o s so f
weight, and a rapidly enlarging upper abdominal mass. The
serum AFP level is almost invariably high [22], suchas in our
case.
The initial diagnosis of HB is mainly based on imaging.
Proper diagnosis, staging, and treatment of HB require
accurate imaging studies. Ultrasound (US) is a noninvasive
modality that is particularly useful in the evaluation of
infants. HB is seen as a hyperechoic, solid, intrahepatic
mass on US [23]. Other standard investigations include
Computed tomography (CT), Magnetic Resonance imaging
(MRI), and serum AFP. However, the ﬁnal diagnosis relies
on tumour biopsy. Furthermore, it is also diﬃcult to
make a pathologic diagnosis of adult HB, since there are
several similar types of tumours such as hepatic teratoma,
carcinosarcoma, malignant mesenchymal tumor, and HCC
with sarcomatous changes and hepatoblastomatous lesions
[16].
The complete surgical resection is the cornerstone of
treatment for patients with HB and is the only chance of
an optimal clinical result. Despite this, the improvements
in survival that have occurred over the last three decades
have been the function of standardized chemotherapy that
reduces tumor size and enables complete tumor excision,
even permitting cure in the presence of initially unresectable
or metastatic disease [24]. Chemotherapy has been proven
eﬀective in both an adjuvant and neoadjuvant treatment
and can shrink tumors. It makes them less prone to bleed
and delineates the tumor from the surrounding normal
parenchyma and vascular structures so as to facilitate the
resections. HB is sensitive to such chemotherapy drugs as
doxorubicin, cisplatin, vincristine, 5-FU, and cyclophos-
phamide [25].
In our experience, despite the important role of histo-
logical sample provided by biopsy in deﬁning diagnosis, very
importantistheroleofMRI,morethanultrasonographyand
enhanced CT, in depicting tumor features as size, margins,
and ratio with neighboring organs in order to the best
surgical approach.
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